bumper to bumper warranty blog
Wednesday, March 28, 2012
Amylin rejected $3.5 billion Bristol offer: Bloomberg
(Reuters) - Shares of Amylin Pharmaceuticals Inc rose as much as 51 percent on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers...
jeeps for sale
motor scooters
motobecane
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment